AR021172A1 - Composicion antiprolifica, antioxidante, que comprende una carnitina y un carotenoide - Google Patents

Composicion antiprolifica, antioxidante, que comprende una carnitina y un carotenoide

Info

Publication number
AR021172A1
AR021172A1 ARP990103863A ARP990103863A AR021172A1 AR 021172 A1 AR021172 A1 AR 021172A1 AR P990103863 A ARP990103863 A AR P990103863A AR P990103863 A ARP990103863 A AR P990103863A AR 021172 A1 AR021172 A1 AR 021172A1
Authority
AR
Argentina
Prior art keywords
carotenoid
carnitine
composition
antiprolifica
antioxidante
Prior art date
Application number
ARP990103863A
Other languages
English (en)
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of AR021172A1 publication Critical patent/AR021172A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composicion que comprende como ingredientes activos caracterizantes, la propionil L-carnitina y al menos un carotenoide, típicamente el licopenoextraido del tomate a partir de la prevencion y/o tratamiento terapéutico de varias alteraciones y estados patologicos inducidos por los radicales libresy por el fenomeno de lipoperoxidacion, que puede tener la forma de un suplemento dietario, soporte dietético o de una medicina real.
ARP990103863A 1998-08-03 1999-08-03 Composicion antiprolifica, antioxidante, que comprende una carnitina y un carotenoide AR021172A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998RM000516A IT1302125B1 (it) 1998-08-03 1998-08-03 Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide

Publications (1)

Publication Number Publication Date
AR021172A1 true AR021172A1 (es) 2002-07-03

Family

ID=11406082

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103863A AR021172A1 (es) 1998-08-03 1999-08-03 Composicion antiprolifica, antioxidante, que comprende una carnitina y un carotenoide

Country Status (21)

Country Link
EP (1) EP1102584A2 (es)
JP (1) JP2002522382A (es)
KR (1) KR20010072146A (es)
CN (1) CN1311674A (es)
AR (1) AR021172A1 (es)
AU (1) AU5064199A (es)
BR (1) BR9912703A (es)
CA (1) CA2338035A1 (es)
EE (1) EE200100052A (es)
HK (1) HK1039062A1 (es)
HU (1) HUP0102807A2 (es)
IL (1) IL140797A0 (es)
IS (1) IS5816A (es)
IT (1) IT1302125B1 (es)
MA (1) MA26666A1 (es)
NO (1) NO20010532L (es)
PL (1) PL346161A1 (es)
SK (1) SK1252001A3 (es)
TN (1) TNSN99152A1 (es)
TR (1) TR200100333T2 (es)
WO (1) WO2000007581A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5448284B2 (ja) 2000-06-02 2014-03-19 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム エチレンジシステイン(ec)−薬物結合体
US6923960B2 (en) 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
KR100523562B1 (ko) 2001-10-29 2005-10-25 한국과학기술연구원 손바닥선인장 추출물 및 이로부터 분리된 화합물을함유하는 신경세포 보호용 조성물
JP4527938B2 (ja) * 2002-07-23 2010-08-18 オルビス株式会社 抗酸化用の経口投与組成物
JP4334189B2 (ja) * 2002-07-30 2009-09-30 カゴメ株式会社 Age生成阻害剤
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
ES2320995T3 (es) 2003-04-14 2009-06-01 Nippon Soda Co., Ltd. Derivado de diamina, procedimiento de produccion y farmaco antioxidante.
US9050378B2 (en) 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
JP2007519678A (ja) * 2004-01-28 2007-07-19 ネステク ソシエテ アノニム 皮膚状態を改良しそして皮膚病を予防するための栄養組成物
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
RU2619342C1 (ru) * 2016-02-24 2017-05-15 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Препарат для профилактики и лечения свободнорадикальной патологии у животных
CN113491687A (zh) * 2020-04-02 2021-10-12 常州高新技术产业开发区三维工业技术研究所有限公司 一种解毒药物组合物及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
EP0400547A1 (en) * 1989-06-02 1990-12-05 Abbott Laboratories Parenteral nutrition product
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US5667791A (en) * 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito

Also Published As

Publication number Publication date
BR9912703A (pt) 2001-05-02
CA2338035A1 (en) 2000-02-17
EP1102584A2 (en) 2001-05-30
KR20010072146A (ko) 2001-07-31
SK1252001A3 (en) 2001-08-06
HK1039062A1 (zh) 2002-04-12
TNSN99152A1 (fr) 2005-11-10
IS5816A (is) 2001-01-16
IT1302125B1 (it) 2000-07-31
AU5064199A (en) 2000-02-28
EE200100052A (et) 2002-06-17
ITRM980516A0 (it) 1998-08-03
IL140797A0 (en) 2002-02-10
ITRM980516A1 (it) 2000-02-03
HUP0102807A2 (hu) 2002-03-28
JP2002522382A (ja) 2002-07-23
NO20010532L (no) 2001-03-20
WO2000007581A2 (en) 2000-02-17
PL346161A1 (en) 2002-01-28
CN1311674A (zh) 2001-09-05
TR200100333T2 (tr) 2001-07-23
NO20010532D0 (no) 2001-01-31
MA26666A1 (fr) 2004-12-20
WO2000007581A3 (en) 2000-05-11

Similar Documents

Publication Publication Date Title
AR021172A1 (es) Composicion antiprolifica, antioxidante, que comprende una carnitina y un carotenoide
WO2000011968A8 (en) ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID
ATE462428T1 (de) Behandlung von entzündlichen erkrankungen
BR0107157A (pt) Diagnose e tratamento de condições cardiovasculares
BR0015188A (pt) Composições farmacêuticas
BRPI0506305A (pt) artigos e métodos de tratamento da pele
BR0317891A (pt) Tratamento de ferimentos de pele usando polienilfosfatidil colina e alcanolaminas
BRPI0606393A2 (pt) prevenção de doenças trombóticas com compostos ativos de vitamina d ou similares do mesmo
BRPI0620229A8 (pt) formulação
NO20074318L (no) Anvendelse av en fettsyresammensetning som inneholder DHA for fremstilling av et medisinsk produkt eller et naeringsmiddel for behandling av amyloidoserelaterte sykdommer
AR033325A1 (es) Composicion que comprende una carnitina y glutationa , util para incrementar la absorcion de la glutationa y sinergizar sus efectos, un complemento dietario, medicamento, la utilizacion de una composicion de combinacion para preparar un complemento dietario o un medicamento
MX2021012894A (es) Compuestos ciclicos de fosfato.
BR0210013A (pt) Gel oftálmico de pirenzepina
CY1109051T1 (el) Χρηση καρνιτινων για την προληψη και/ή θεραπεια διαταραχων που προκαλουνται απο την ανδροπαυση
AR023391A1 (es) Composicion que contiene carnitina e inositol fosfato, util como suplemento dietario o droga
ATE554753T1 (de) 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia
NO996468L (no) Anvendelse av gaba-analoger slik som gabapentin i fremstillingen av et medikament for behandling av betennelsessykdommer
AR019737A4 (es) Composicion antioxidante, citostatica y de energia sostenida que mejora la utilizacion metabolica de glucosa
AR021089A1 (es) Composicion preventiva antioxidante contra anormalidades tromboticas y ateroscleroticas, que comprende una carnitina y un flavonoide
PE20031047A1 (es) Tratamiento de padecimientos post-menopausicos en pacientes con cancer de mama
NO984759L (no) Anvendelse av en osmolytt ved fremstilling av et medikament for behandling av komplikasjoner forÕrsaket av iskemi
UY26230A1 (es) Una combinación sinergética: gabapentina y pregabalina
AR024981A1 (es) Composicion para la prevencion y el tratamiento de las disfunciones y enfermedades del rinon
ES2196456T3 (es) Compuestos ciclicos de cinco eslabones en el anillo condensado que llevan un grupo sulfonamida, su uso como medicamentos y composiciones farmaceuticas que los contienen.
TR200401572T4 (tr) Lipid-Metabolizması bozuklukları-alerjik formların önlenmesi ve/veya tedavisi için bileşim